Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
92 hedge funds and large institutions have $458M invested in Gritstone bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 21 closing their positions.
44% more capital invested
Capital invested by funds: $318M → $458M (+$140M)
13% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 31
10% less funds holding
Funds holding: 102 → 92 (-10)
30% less call options, than puts
Call options by funds: $5.34M | Put options by funds: $7.64M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
+$33.1M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$21.3M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$19.5M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$5.41M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.02M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.62M |
| 3 |
VVM
Versant Venture Management
San Francisco,
California
|
-$4.05M |
| 4 |
Two Sigma Investments
New York
|
-$3.62M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$2.72M |
GRTS Hedge Fund Activity: Q3 2021 in Review
92 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2021, worth a combined $458M — up 44% from $318M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of GRTS and 12 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 35 added.
The largest buyer was Frazier Management, adding an estimated $33.1M. The largest seller was Wellington Management Group, exiting entirely with an estimated $9.02M sold.
- 92 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2021, down from 102 in Q2 2021.
- Funds reported $458M of Gritstone bio, Inc. Common Stock stock for Q3 2021, up 44% quarter-over-quarter.
- 12 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2021 and 21 closed out, a net change of -9 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q3 2021 was Frazier Management, an estimated $33.1M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q3 2021 was Wellington Management Group, an estimated $9.02M sold.
Based on aggregated 13F filings for Q3 2021.